Live Breaking News & Updates on Oliver Sartor|Page 4

Stay updated with breaking news from Oliver sartor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr Sartor on Efficacy and Safety of Lutetium Lu 177 Vipivotide Tetraxetan in Taxane-Naive mCRPC

Oliver Sartor, MD, discusses updated efficacy findings from the phase 3 PSMAfore trial of lutetium Lu 177 vipivotide tetraxetan in patients with previously treated, taxane-naive metastatic castration-resistant prostate cancer. ....

Oliver Sartor , Mayo Clinic , Prostate Cancer , Lutetium Lu 177 Vipivotide Tetraxetan , Taxane Naive Mcrpc , Phase 3 Psmafore Trial Nct04689828 ,